Insider · CIK 0001253886

Enright Patrick G

CIK 0001253886 Name as filed on the most recent filing

Filed as Enright Patrick G (105)

366 transaction lines · from 105 filings · filed 2005-02-09 to 2026-02-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

321 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-09-06 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 343,305, disposed Open Form 4 filing 0001232524-18-000167
2018-09-06 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 169,694, disposed Open Form 4 filing 0001232524-18-000167
2018-08-10 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 239,057, disposed Open Form 4 filing 0001232524-18-000138
2018-07-02 P, Open-market purchase Tricida, Inc.TCDA 2,500,001, acquired Open Form 4 filing 0001140361-18-031069
2018-06-25 P, Open-market purchase Aptinyx Inc.APTX 2,400,000, acquired Open Form 4 filing 0001104659-18-042306
2018-02-22 P, Open-market purchase Aimmune Therapeutics, Inc.AIMT 498,976, acquired Open Form 4 filing 0001209191-18-013348
2017-12-11 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 3 lines 1,257,582, disposed Open Form 4 filing 0001232524-17-000185
2017-12-08 S, Open-market sale Collegium Pharmaceutical, IncCOLL 2 lines 17,340,000, disposed Open Form 4 filing 0001209191-17-065191
2017-11-17 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 46,883, disposed Open Form 4 filing 0001232524-17-000181
2017-08-25 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 52,088, disposed Open Form 4 filing 0001232524-17-000158
2017-08-11 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 2 lines 94,248, disposed Open Form 4 filing 0001232524-17-000138
2017-07-25 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 3,225,000, acquired Open Form 4 filing 0001209191-17-046462
2017-03-16 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 2,683,237, disposed Open Form 4 filing 0001209191-17-021733
2017-03-15 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 2,856,766, disposed Open Form 4 filing 0001209191-17-020909
2017-03-14 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 3,002,670, disposed Open Form 4 filing 0001209191-17-020909
2017-03-13 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 233,491, disposed Open Form 4 filing 0001209191-17-020909
2017-03-08 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 7,312,500, disposed Open Form 4 filing 0001209191-17-019850
2017-02-27 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 9,050,000, disposed Open Form 4 filing 0001209191-17-014958
2017-02-23 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 12,975,000, disposed Open Form 4 filing 0001209191-17-014958
2016-12-02 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 68,919, disposed Open Form 4 filing 0001232524-16-000390
2016-11-25 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 138,372, disposed Open Form 4 filing 0001209191-16-152055
2016-11-23 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 117,228, disposed Open Form 4 filing 0001209191-16-152055
2016-11-22 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 89,565, disposed Open Form 4 filing 0001209191-16-152055
2016-11-21 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 1,111,162, disposed Open Form 4 filing 0001209191-16-151522
2016-11-18 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 952,684, disposed Open Form 4 filing 0001209191-16-151522
2016-11-17 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 3,135,580, disposed Open Form 4 filing 0001209191-16-151522
2016-11-16 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 165,394, disposed Open Form 4 filing 0001209191-16-150891
2016-11-15 S, Open-market sale Corcept Therapeutics IncCORT 2 lines 1,504,211, disposed Open Form 4 filing 0001209191-16-150891
2016-08-15 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 86,373, disposed Open Form 4 filing 0001232524-16-000347
2016-03-29 P, Open-market purchase Aimmune Therapeutics, Inc.AIMT 2 lines 1,089,135, acquired Open Form 4 filing 0001209191-16-111235

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 35
  • Open-market sale 286
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. ENRIGHT PATRICK G, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001253886

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.